XML 34 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)
9 Months Ended
Sep. 30, 2013
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities  
Schedule of marketable investment securities, restricted cash and other investment securities

 

 

 

 

As of

 

 

 

September 30,

 

December 31,

 

 

 

2013

 

2012

 

 

 

(In thousands)

 

Marketable investment securities:

 

 

 

 

 

Current marketable investment securities - VRDNs

 

$

149,920

 

$

130,306

 

Current marketable investment securities - strategic

 

1,377,727

 

1,261,015

 

Current marketable investment securities - other

 

3,981,090

 

2,240,316

 

Total current marketable investment securities

 

5,508,737

 

3,631,637

 

Restricted marketable investment securities (1)

 

72,800

 

51,366

 

Noncurrent marketable investment securities - ARS and other (2)

 

126,856

 

106,172

 

Total marketable investment securities

 

5,708,393

 

3,789,175

 

 

 

 

 

 

 

Restricted cash and cash equivalents (1)

 

22,354

 

83,044

 

 

 

 

 

 

 

Other investment securities:

 

 

 

 

 

Other investment securities - cost method (2)

 

15,104

 

12,879

 

Total other investment securities

 

15,104

 

12,879

 

 

 

 

 

 

 

Total marketable investment securities, restricted cash and cash equivalents, and other investment securities

 

$

5,745,851

 

$

3,885,098

 

 

(1)         Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash and marketable investment securities” on our Condensed Consolidated Balance Sheets.

(2)          Noncurrent marketable investment securities — auction rate securities (“ARS”) and other investment securities are included in “Marketable and other investment securities” on our Condensed Consolidated Balance Sheets.

Schedule of unrealized gain (loss) on marketable investment securities

 

 

 

 

As of September 30, 2013

 

As of December 31, 2012

 

 

 

Fair

 

Unrealized

 

Fair

 

Unrealized

 

 

 

Value

 

Gains

 

Losses

 

Net

 

Value

 

Gains

 

Losses

 

Net

 

 

 

(In thousands)

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

VRDNs

 

$

149,920

 

$

 

$

 

$

 

$

130,306

 

$

 

$

 

$

 

ARS and other

 

45,430

 

1,200

 

(5,150

)

(3,950

)

43,921

 

1,375

 

(8,033

)

(6,658

)

ARS fair value election

 

81,426

 

 

 

 

62,251

 

 

 

 

Other (including restricted)

 

4,989,642

 

175,922

 

(1,507

)

174,415

 

3,287,317

 

208,208

 

(1,203

)

207,005

 

Equity securities

 

441,975

 

75,012

 

(15,555

)

59,457

 

265,380

 

17,918

 

(11,537

)

6,381

 

Total

 

$

5,708,393

 

$

252,134

 

$

(22,212

)

$

229,922

 

$

3,789,175

 

$

227,501

 

$

(20,773

)

$

206,728

Schedule of available-for-sale securities in continuous unrealized loss position by length of time and their fair value

 

 

 

 

As of

 

 

 

September 30, 2013

 

December 31, 2012

 

 

 

Fair

 

Unrealized

 

Fair

 

Unrealized

 

 

 

Value

 

Loss

 

Value

 

Loss

 

 

 

(In thousands)

 

Debt Securities:

 

 

 

 

 

 

 

 

 

Less than 12 months

 

$

1,679,098

 

$

(936

)

$

761,551

 

$

(909

)

12 months or more

 

121,978

 

(5,721

)

72,395

 

(8,327

)

Equity Securities:

 

 

 

 

 

 

 

 

 

Less than 12 months

 

137,995

 

(15,555

)

154,566

 

(11,537

)

12 months or more

 

 

 

 

 

Total

 

$

1,939,071

 

$

(22,212

)

$

988,512

 

$

(20,773

)

Schedule of fair value measurements

 

 

 

 

As of

 

 

 

September 30, 2013

 

December 31, 2012

 

 

 

Total

 

Level 1

 

Level 2

 

Level 3

 

Total

 

Level 1

 

Level 2

 

Level 3

 

 

 

(In thousands)

 

Cash equivalents (including restricted)

 

$

4,480,912

 

$

305,875

 

$

4,175,037

 

$

 

$

3,386,929

 

$

67,833

 

$

3,319,096

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

VRDNs

 

$

149,920

 

$

 

$

149,920

 

$

 

$

130,306

 

$

 

$

130,306

 

$

 

ARS and other

 

126,856

 

 

740

 

126,116

 

106,172

 

 

955

 

105,217

 

Other (including restricted)

 

4,989,642

 

11,033

 

4,975,142

 

3,467

 

3,287,317

 

11,182

 

3,276,135

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity securities

 

441,975

 

441,975

 

 

 

265,380

 

265,380

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

5,708,393

 

$

453,008

 

$

5,125,802

 

$

129,583

 

$

3,789,175

 

$

276,562

 

$

3,407,396

 

$

105,217

Schedule of changes in Level 3 instruments

 

 

 

 

Level 3

 

 

 

Investment

 

 

 

Securities

 

 

 

(In thousands)

 

Balance as of December 31, 2012

 

$

105,217

 

Net realized and unrealized gains (losses) included in earnings

 

19,289

 

Net realized and unrealized gains (losses) included in other comprehensive income (loss)

 

2,961

 

Purchases

 

3,480

 

Settlements

 

(1,364

)

Issuances

 

 

Transfers into or out of Level 3

 

 

Balance as of September 30, 2013

 

$

129,583

Schedule of gains and losses on sales and changes in carrying values of investments

 

 

 

For the Three Months

 

For the Nine Months

 

 

 

Ended September 30,

 

Ended September 30,

 

Other Income (Expense):

 

2013

 

2012

 

2013

 

2012

 

 

 

(In thousands)

 

Marketable investment securities - gains (losses) on sales/exchanges

 

$

49,223

 

$

111,709

 

$

63,405

 

$

119,445

 

Marketable investment securities - unrealized gains (losses) on investments accounted for at fair value

 

8,689

 

667

 

19,175

 

(2,395

)

Marketable investment securities - gains (losses) on conversion of DBSD North America Notes (1)

 

 

 

 

99,445

 

Derivative financial instruments - net realized and/or unrealized gains (losses)

 

42,301

 

 

126,832

 

 

Marketable investment securities - other-than-temporary impairments

 

 

(42,811

)

(1,919

)

(45,292

)

Other

 

5,534

 

266

 

5,235

 

1,462

 

Total

 

$

105,747

 

$

69,831

 

$

212,728

 

$

172,665

 

 

(1)          During the nine months ended September 30, 2012, we recognized a $99 million non-cash gain related to the conversion of our DBSD North America 7.5% Convertible Senior Secured Notes due 2009 in connection with the completion of the DBSD Transaction.